Modeling glioblastoma invasion using human brain organoids and single-cell transcriptomics

Abstract

Taken together, our model has proven useful for studying GBM invasion and transcriptional heterogeneity in vitro, with applications for both pharmacological screens and patient-specific treatment selection on a time scale amenable to clinical practice.